Oral sirolimus therapy for patients with complex low-flow vascular malformations
Oral sirolimus therapy was clinically effective and safe in patients with complex LFVMs when standard therapy alone was inadequate. Further studies with longer follow-up are needed to evaluate oral sirolimus therapy in LFVM patients.
Authors
- Rebecca Nisbet (ORCID: https://orcid.org/0009-0007-0137-1865)
- Nicholas Evans
- Chung Sim Lim (ORCID: https://orcid.org/0000-0001-9319-7751)
- Tejinder Randhawa
- Jocelyn Brookes
- Calver Pang (ORCID: https://orcid.org/0000-0001-9914-4706)
- Mohamed Khalifa (ORCID: https://orcid.org/0000-0002-6709-4019)
- Anthie M. Papadopoulou
- Ahmed Belhadh
Institutions
- Royal Free London NHS Foundation Trust (GB)
- University College London (GB)
Publication Details
- Journal
- Journal of Vascular Surgery Venous and Lymphatic Disorders
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1016/j.jvsv.2025.102261
- Citations
- 1
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- National Institute for Health and Care Research
- University College London